Rauchova 2005 Biochem Biophys Res Comm: Difference between revisions

From Bioblast
No edit summary
No edit summary
Β 
(5 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{Publication
{{Publication
|title=Rauchova H, Vrbacky M, Bergamini C, Fato R, Lenaz G, Houstek J, Drahota Z (2005) Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone. Biochem Biophys Res Comm 339: 362-366.
|title=Rauchova H, Vrbacky M, Bergamini C, Fato R, Lenaz G, Houstek J, Drahota Z (2005) Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone. Biochem Biophys Res Comm 339:362-6.
|info=[http://www.ncbi.nlm.nih.gov/pubmed/16300743 PMID: 16300743]
|info=[http://www.ncbi.nlm.nih.gov/pubmed/16300743 PMID: 16300743]
|authors=Rauchova H, Vrbacky M, Bergamini C, Fato R, Lenaz G, Houstek J, Drahota Z
|authors=Rauchova H, Vrbacky M, Bergamini C, Fato R, Lenaz G, Houstek J, Drahota Z
Line 7: Line 7:
|abstract=The established protective effect of coenzyme Q (CoQ) analogs is dependent on the location of reactive oxygen species (ROS) generation. One of these analogsβ€”idebenone (hydroxydecyl-ubiquinone) is used as an antioxidative therapeutic drug. We tested its scavenging effect on the glycerophosphate (GP)-dependent ROS production as this enzyme was shown as a new site in the mitochondrial respiratory chain where ROS can be generated. We observed that idebenone inhibits both GP- and succinate-dependent ROS production. Idebenone and CoQ<sub>1</sub>Β  were found to be more efficient in the scavenging activity (IC<sub>50</sub> : 0.052 and 0.075 ΞΌM, respectively) than CoQ<sub>3</sub> (IC<sub>50</sub> : 45.8 ΞΌM). Idebenone also inhibited ferricyanide (FeCN)-activated, GP-dependent ROS production. Our data thus extend previous findings on the scavenging effect of idebenone and show that it can also eliminate GP-dependent ROS generation
|abstract=The established protective effect of coenzyme Q (CoQ) analogs is dependent on the location of reactive oxygen species (ROS) generation. One of these analogsβ€”idebenone (hydroxydecyl-ubiquinone) is used as an antioxidative therapeutic drug. We tested its scavenging effect on the glycerophosphate (GP)-dependent ROS production as this enzyme was shown as a new site in the mitochondrial respiratory chain where ROS can be generated. We observed that idebenone inhibits both GP- and succinate-dependent ROS production. Idebenone and CoQ<sub>1</sub>Β  were found to be more efficient in the scavenging activity (IC<sub>50</sub> : 0.052 and 0.075 ΞΌM, respectively) than CoQ<sub>3</sub> (IC<sub>50</sub> : 45.8 ΞΌM). Idebenone also inhibited ferricyanide (FeCN)-activated, GP-dependent ROS production. Our data thus extend previous findings on the scavenging effect of idebenone and show that it can also eliminate GP-dependent ROS generation
|keywords=Mitochondrial glycerophosphate dehydrogenase, Succinate dehydrogenase, Reactive oxygen species, debenone, Coenzyme Q analogs
|keywords=Mitochondrial glycerophosphate dehydrogenase, Succinate dehydrogenase, Reactive oxygen species, debenone, Coenzyme Q analogs
|mipnetlab=CZ Prague Houstek J, IT Bologna Lenaz G, IT Bologna Genova ML
|discipline=Pharmacology; Biotechnology
|discipline=Pharmacology; Biotechnology
}}
}}
{{Labeling
{{Labeling
|area=Respiration
|injuries=Oxidative stress;RONS
|pathways=S, Gp, Other combinations
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|enzymes=Complex II; Succinate Dehydrogenase, Complex III
|topics=Respiration; OXPHOS; ETS Capacity, Flux Control; Additivity; Threshold; Excess Capacity
|discipline=Pharmacology; Biotechnology
|discipline=Pharmacology; Biotechnology
}}
}}

Latest revision as of 13:53, 27 March 2018

Publications in the MiPMap
Rauchova H, Vrbacky M, Bergamini C, Fato R, Lenaz G, Houstek J, Drahota Z (2005) Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone. Biochem Biophys Res Comm 339:362-6.

Β» PMID: 16300743

Rauchova H, Vrbacky M, Bergamini C, Fato R, Lenaz G, Houstek J, Drahota Z (2005) Biochem. Biophys. Res. Commun.

Abstract: The established protective effect of coenzyme Q (CoQ) analogs is dependent on the location of reactive oxygen species (ROS) generation. One of these analogsβ€”idebenone (hydroxydecyl-ubiquinone) is used as an antioxidative therapeutic drug. We tested its scavenging effect on the glycerophosphate (GP)-dependent ROS production as this enzyme was shown as a new site in the mitochondrial respiratory chain where ROS can be generated. We observed that idebenone inhibits both GP- and succinate-dependent ROS production. Idebenone and CoQ1 were found to be more efficient in the scavenging activity (IC50 : 0.052 and 0.075 ΞΌM, respectively) than CoQ3 (IC50 : 45.8 ΞΌM). Idebenone also inhibited ferricyanide (FeCN)-activated, GP-dependent ROS production. Our data thus extend previous findings on the scavenging effect of idebenone and show that it can also eliminate GP-dependent ROS generation β€’ Keywords: Mitochondrial glycerophosphate dehydrogenase, Succinate dehydrogenase, Reactive oxygen species, debenone, Coenzyme Q analogs

β€’ O2k-Network Lab: CZ Prague Houstek J, IT Bologna Lenaz G, IT Bologna Genova ML


Labels: MiParea: Respiration 

Stress:Oxidative stress;RONS 




Pathway: S, Gp, Other combinations  HRR: Oxygraph-2k 


Cookies help us deliver our services. By using our services, you agree to our use of cookies.